• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

rtothill@unimelb.edu.au

Credentials


Position
Principal Res Fellow, Cancer Genomics Group Leader
Department of Clinical Pathology
Education
PhD
University of Melbourne
Bachelors Degree (Honours)
Murdoch University
ORCID

0000-0003-4522-1184

A/Prof Richard Tothill

Principal Res Fellow, Cancer Genomics Group Leader
Department of Clinical Pathology

113 Scholarly works
26 Projects

HIGHLIGHTS

  • 2020

    Research grants (ARC, NHMRC, MRFF)

    Super-Next: Complete Genome Profiling for Cancer of Unknown Primary
  • 2020

    Research Grant

    Super-Next: Complete Genome Profiling for Cancer of Unknown Primary
  • 2020

    Research grants (ARC, NHMRC, MRFF)

    Evaluation of Fibroblastic Activation Protein Inhibitors (FAPI) as a Novel Radiopharmaceutical Targeting Cancer-Associated Fibroblasts for the Diagnosis and Treatment of Patients With Cancer of Unknown Primary: The FAPI-CUP Trial
  • 2015

    Journal article

    Whole-genome characterization of chemoresistant ovarian cancer
    DOI: 10.1038/nature14410
  • 2014

    Journal article

    Bioinformatics pipelines for targeted resequencing and whole-exome sequencing of human and mouse genomes: A virtual appliance approach for instant deployment
    DOI: 10.1371/journal.pone.0095217
  • 2013

    Journal article

    Targeted-capture massively-parallel sequencing enables robust detection of clinically informative mutations from formalin-fixed tumours
    DOI: 10.1038/srep03494
  • 2013

    Journal article

    Massively-parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primary
    DOI: 10.1002/path.4251
Richard Tothill

RECENT SCHOLARLY WORKS

  • 2025

    Journal article

    Duplex-Specific DNase Signal Amplification Allows Attomolar Electrochemical Detection of MicroRNAs
    DOI: 10.1002/smll.202507997
  • 2025

    Journal article

    762MO Clinical whole genome and transcriptome sequencing for cancer of unknown primary: An Australian prospective observational study
    DOI: 10.1016/j.annonc.2025.10.1177
  • 2025

    Journal article

    Solving unknown primary cancer with earlier diagnosis - the SUPER-ED trial: study protocol for a stepped-wedge cluster randomised controlled trial to support earlier diagnosis for people presenting with malignancy of undefined primary origin
    DOI: 10.1186/s12885-025-13506-4
  • 2025

    Journal article

    Pathologist-initiated whole genome and transcriptome sequencing demonstrates diagnostic utility in resolving difficult-to-diagnose tumors
    DOI: 10.1186/s13073-025-01534-5
  • 2025

    Journal article

    Whole genome sequencing improves tissue-of-origin diagnosis and treatment options for cancer of unknown primary
    DOI: 10.1038/s41467-025-59661-x
  • 2025

    Journal article

    Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profiles
    DOI: 10.1038/s41467-025-57595-y
  • 2024

    Journal article

    Disruption of metazoan gene regulatory networks in cancer alters the balance of co-expression between genes of unicellular and multicellular origins
    DOI: 10.1186/s13059-024-03247-1
  • 2024

    Journal article

    Recent progress in molecular classification of phaeochromocytoma and paraganglioma
    DOI: 10.1016/j.beem.2024.101939

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224